Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The impact of prostate volume changes during external-beam irradiation in consequence of HDR brachytherapy in prostate cancer treatment.

Herrmann MK, Gsänger T, Strauss A, Kertesz T, Wolff HA, Christiansen H, Vorwerk H, Hess CF, Hille A.

Strahlenther Onkol. 2009 Jun;185(6):397-403. doi: 10.1007/s00066-009-1942-7. Epub 2009 Jun 9.

PMID:
19506824
2.

Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.

Hsu IC, Pickett B, Shinohara K, Krieg R, Roach M 3rd, Phillips T.

Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):851-8.

PMID:
10705005
3.

Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: a prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study.

Herrmann MK, Kertesz T, Gsänger T, Bloch E, Pollul G, Bouabdallaoui M, Strauss A, Herrmann M, Christiansen H, Wolff HA, Hess CF, Hille A.

Radiat Oncol. 2012 Feb 20;7:24. doi: 10.1186/1748-717X-7-24.

4.

Prostate CT segmentation method based on nonrigid registration in ultrasound-guided CT-based HDR prostate brachytherapy.

Yang X, Rossi P, Ogunleye T, Marcus DM, Jani AB, Mao H, Curran WJ, Liu T.

Med Phys. 2014 Nov;41(11):111915. doi: 10.1118/1.4897615.

5.

An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer.

Yan D, Lockman D, Brabbins D, Tyburski L, Martinez A.

Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):289-302.

PMID:
10925000
6.
7.

Prostate target volume variations during a course of radiotherapy.

Antolak JA, Rosen II, Childress CH, Zagars GK, Pollack A.

Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):661-72.

PMID:
9806528
8.

Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.

Sanguineti G, Castellone P, Foppiano F, Franzone P, Marcenaro M, Tognoni P, Bolognesi A, Ceresoli GL, Fiorino C.

Strahlenther Onkol. 2004 Sep;180(9):563-72.

PMID:
15378187
9.

3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer.

Martin T, Röddiger S, Kurek R, Dannenberg T, Eckart O, Kolotas C, Heyd R, Rogge B, Baltas D, Tunn U, Zamboglou N.

Radiother Oncol. 2004 Apr;71(1):35-41.

PMID:
15066294
10.

[Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].

Sefrová J, Paluska, Odrázka K, Belobradek Z, Hoffmann P, Prosvic P, Brod'ák M, Louda M, Macingová Z, Vosmik M.

Klin Onkol. 2010;23(4):256-63. Czech.

PMID:
20806824
11.

Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.

Martinez AA, Pataki I, Edmundson G, Sebastian E, Brabbins D, Gustafson G.

Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):61-9.

PMID:
11163498
12.

Accelerated partial breast irradiation: a dosimetric comparison of three different techniques.

Weed DW, Edmundson GK, Vicini FA, Chen PY, Martinez AA.

Brachytherapy. 2005;4(2):121-9.

PMID:
15893265
13.

A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy.

Hermesse J, Biver S, Jansen N, Lenaerts E, De Patoul N, Vynckier S, Coucke P, Scalliet P, Nickers P.

Strahlenther Onkol. 2009 Nov;185(11):736-42. doi: 10.1007/s00066-009-2009-5. Epub 2009 Nov 10.

PMID:
19899007
14.

Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial.

Martinez A, Gonzalez J, Stromberg J, Edmundson G, Plunkett M, Gustafson G, Brown D, Yan D, Vicini F, Brabbins D.

Int J Radiat Oncol Biol Phys. 1995 Dec 1;33(5):1019-27.

PMID:
7493828
16.

Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.

Murray L, Mason J, Henry AM, Hoskin P, Siebert FA, Venselaar J, Bownes P; UroGEC/BRAPHYQS group of the GEC ESTRO.

Radiother Oncol. 2016 Aug;120(2):293-9. doi: 10.1016/j.radonc.2016.05.026. Epub 2016 Jun 29.

PMID:
27370205
18.

Dosimetric effect of external beam planning preceding combined high-dose-rate brachytherapy of the prostate.

Martin JM, Brett R, Blyth J, Morrison S, Bryant D, Plank A, Cheuk R, Fay M, Dickie G, Yaxley J.

Brachytherapy. 2011 Nov-Dec;10(6):474-8. doi: 10.1016/j.brachy.2010.10.003. Epub 2010 Nov 26.

PMID:
21111686
19.

Evaluation of dosimetric margins in prostate IMRT treatment plans.

Gordon JJ, Siebers JV.

Med Phys. 2008 Feb;35(2):569-75.

20.

3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study.

Martin T, Baltas D, Kurek R, Röddiger S, Kontova M, Anagnostopoulos G, Dannenberg T, Buhleier T, Skazikis G, Tunn U, Zamboglou N.

Strahlenther Onkol. 2004 Apr;180(4):225-32.

PMID:
15057433

Supplemental Content

Support Center